Clinical Trials

80 enrolled 13 charts

Neoplasm Metastasis, Neoplasms

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

472 enrolled

Phase 1 Active not recruiting

Neoplasms

NCT02379520 2025-11-28

HESTIA

32 enrolled

Neoplasms, Recurrence

NCT02812667 2025-11-12

Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

18 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT03963518 2025-10-06

SURROGATE-ICI

Completed

631 enrolled 6 charts

Phase 2 Active not recruiting

Neoplasms

NCT04095208 2025-10-02

CONGRATS

67 enrolled

Sarcoma

Tertiary Lymphoid Structures, Neoplasm Metastasis, Neoplasms, Sarcoma

NCT03697564 2025-08-06

Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer

2 enrolled 10 charts

Neoplasms, Pancreatic Neoplasms

NCT04572451 2025-08-01

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

Phase 1 Recruiting

50 enrolled

Dermatologic

Melanoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site

NCT06031233 2025-05-21

MINUTE

Phase 4 Recruiting

679 enrolled

Neoplasms

NCT03296137 2024-10-26

Adoptive Cell Therapy Across Cancer Diagnoses

Phase 1/2 Completed

25 enrolled 9 charts

Neoplasms

NCT05655715 2024-10-16

CheckPRO

90 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT03409198 2024-10-15

ICON

82 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT02664181 2024-09-03

PRECISE

13 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT03299946 2024-09-03

Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resection for Patients With Locally Advanced Hepatocellular Carcinoma (HCC)

Phase 1 Completed

15 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT03190265 2024-08-07

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

61 enrolled 11 charts

Adenocarcinoma, Carcinoma, Neoplasms, Pancreatic Neoplasms

NCT05153304 2024-06-10

Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers

Phase 1/2 Withdrawn

Phase 2 Active not recruiting

Gastrointestinal Neoplasms, Neoplasms

NCT05964101 2024-05-21

GALAXY-1

Phase 2 Recruiting

25 enrolled

Carcinoma, Squamous Cell, Neoplasms, Tracheal Neoplasms

NCT04300244 2024-02-29

NIPU

118 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma, Neoplasms

NCT05150236 2023-12-15

ANZUP2001

Phase 2 Unknown

93 enrolled

Genitourinary

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT04984733 2023-11-29

ELEVATE

Phase 2 Recruiting

18 enrolled

Esophageal Neoplasms, Neoplasms

NCT05767684 2023-08-25

Neoantigen Derived DCs as Cancer Treatment

Phase 1 Recruiting

12 enrolled

Neoplasms

NCT04801966 2023-05-10

TAILOR

Phase NA Terminated

3 enrolled

Neoplasms

NCT05175235 2023-03-03

Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements

Phase 1/2 Unknown

10 enrolled

Neoplasms

NCT03431948 2023-02-16

C4-MOSART

Phase 1 Completed

60 enrolled

Neoplasms

NCT03792724 2019-01-03

INTRUST

Phase 1/2 Unknown

32 enrolled